Metastatic Breast Cancer

An Open-label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

The Full paper of this clinical studies is available upon request In Conclusion, compared with standard paclitaxel, Paxus PM or Genexol-PM demonstrat...

A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

No abstract available. Trial is ongoing.

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

Abstract Genexol-PM is a novel Cremophor EL-free polymeric micelle formulation of paclitaxel. This single arm, multicenter phase II study was designed to evaluate the efficacy and safety of Genexol-PM in patients with histologically confirmed metastatic breast cancer (MBC)...
Brand Name: PAXUS™ PM (South East Asia), GENEXOL® PM (Korea & other territories)